Fate of Trypanosoma cruzi, the causative agent of Chagas disease, in bed bugs after oral ingestion or intrathoracic injection. [PDF]
Meraj S +4 more
europepmc +1 more source
Trypanosoma cruzi: A new system for primary culture and isolation of the parasite. [PDF]
Vanegas MA +3 more
europepmc +1 more source
Chagas disease: host responses, parasite evasion and vaccine advances. [PDF]
Serrano-Coll H.
europepmc +1 more source
Asymptomatic Trypanosoma cruzi Infection Identified During Blood Donation Screening. [PDF]
Ngo JM, Maknojiya AN, Patel RY, Meza A.
europepmc +1 more source
Placental Barrier Breakdown Induced by <i>Trypanosoma cruzi</i>-Derived Exovesicles: A Role for MMP-2 and MMP-9 in Congenital Chagas Disease. [PDF]
Fernández-Moya A +7 more
europepmc +1 more source
Haemanthidine-Containing Alkaloid Fraction from <i>Crinum scabrum</i> as a Natural Therapeutics for Chagas Disease. [PDF]
Pardo JB +7 more
europepmc +1 more source
Oral Route Infection by <i>Trypanosoma cruzi:</i> From the Beginning to the Present Day. [PDF]
Zambrano S +6 more
europepmc +1 more source
<i>In Vitro</i> Activity of Pterocarpanquinone LQB-118 on <i>Trypanosoma cruzi</i> and Its Impact on Parasite Bioenergetics. [PDF]
Azevedo BF +11 more
europepmc +1 more source
RIG-I-Adjuvanted Immunogen Elicited T-Cell Immunity Controls Trypanosoma cruzi, Chagasic Cardiomyopathy, and Left Ventricular Dysfunction. [PDF]
Lokugamage N +7 more
europepmc +1 more source
Advancing <i>Trypanosoma cruzi</i> N-myristoyltransferase as a drug target for Chagas disease through <i>in silico</i> discovery and biochemical evaluation. [PDF]
González García D +9 more
europepmc +1 more source

